4/1/2022CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...

4/1/2022Recent Executive Moves

4/1/2022Cancer Statistics in China and United States 2022: Profiles, Trends an...

4/1/2022More Clouds over Multiple Fronts of Chinese Pharma as Geopolitical Ris...

3/31/2022China's Ministry of Science and Technology Publishes Draft Rules on th...

3/31/2022More JAK Therapies for Atopic Dermatitis Expected in China (PharmaDJ)

3/31/2022NMPA Publishes 2021 Annual Report for Adverse Drug Reaction Monitoring

3/31/2022CDE Solicits Comments on the Inspection Checkpoints of Drug MAHs (Draf...

3/31/2022Financial-related Company News Digest (March 2022)

3/31/2022Drug R&D and Product Registration News Digest March 2022 (5)

3/31/2022Recent Executive Moves

3/30/2022'In the Long-Term Interests': FDA Oncology Chief Defends Rejection of ...

3/30/2022As Lilly, Innovent Hit FDA Rebuff, Another China-made PD-1 Cancer Drug...

3/30/2022Brii Bio Enters Strategic Partnership with Sinopharm to Advance Commer...

3/30/2022Biosion Licenses BSI-060T (Anti-Siglec-15) to Pyxis Oncology

3/30/2022IQVIA: Chinese Retail Pharmacy Sales Up 0.6% in Q4/2021

3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability

3/29/2022NHC and NMPA Solicits Comments on Two Documents on Temporary Import Wo...

3/29/2022Shanghai Lockdown May Choke Pharma Supplies (ET)

3/28/2022Fosun Pharma Hopes Covid Vaccine Can Cure Its Ailing Margins

3/28/2022Innovent and Lilly Expand Strategic Partnership in Oncology

3/28/2022Upcoming Event: 5th European Meeting on Materials Science and Nanotech...

3/28/2022China Approves Takeda's Lung Cancer Drug Brigatinib

3/28/2022BRICS Launches Vaccine R&D Center

3/25/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (57...

3/25/2022Drug R&D and Product Registration News Digest March 2022 (4)

3/24/2022Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chine...

3/24/2022Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...

3/24/2022Eli Lilly/Innovent Announce Lung Cancer Drug Rejection by FDA Citing...

3/24/2022What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)

Page:160/789 Total number of articles:23668: [First][<<] [158] [159] [160] [161] [162] [>>] [End]